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Abstract: The present study evaluated whether the magnetic nanoparticles of Fe3O4 
(MNPs-Fe3O4) could enhance the activity of artesunate (ART), and to explore its potential 
mechanisms. Cytotoxicity of the copolymer of ART with MNPs-Fe3O4 on K562 cells was 
detected by MTT assay and the apoptosis rate of K562 cells was measured by flow cytometry. 
Protein expression levels of bcl-2, bax, bcl-rambo, caspase-3, and survivin in K562 cells were 
measured by Western blot. After being incubated with the copolymer of ART with MNPs-Fe3O4 
for 48 hours, the growth inhibition rate of K562 cells was significantly increased compared 
with that of K562 cells treated with ART alone (P , 0.05), and the apoptosis rate of K562 cells 
was increased significantly compared with that of K562 cells treated with ART alone, suggest-
ing that MNPs-Fe3O4 can enhance the activity of ART. Interestingly, the copolymer-induced 
cell death was attenuated by caspase inhibitor Z-VAD-FMK. Our results also showed that 
treatment with the copolymer of MNPs-Fe3O4 and ART increased the expression of bcl-2, 
bax, bcl-rambo, and caspase-3 proteins, and decreased the expression of survivin protein in 
K562 cells compared with ART treatment alone. These results suggest that MNPs-Fe3O4 can   
enhance ART-induced apoptosis, which may be related to the upregulation of bcl-rambo and 
downregulation of survivin.
Keywords: magnetic nanoparticles, MNPs-Fe3O4, artesunate, K562 cells, apoptosis, 
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Introduction
Artesunate (ART), a semi-synthetic derivative of artemisinin extracted from the   Chinese 
herb Artemisia annua, is a safe and effective antimalarial drug. Recently, several   studies 
showed that ART could inhibit the growth of various carcinoma cell lines1–3 and sup-
press tumor cell proliferation by inducing apoptosis,4 indicating that ART may be a 
promising novel candidate for leukemia therapy. However, a variety of lines of evidence 
indicate that ART inhibited cell proliferation in a dose-dependent manner, and a high 
concentration of ART induced embryo toxicity,5–7 reversible renal damage toxicity,8 
and toxicity to bone development,9 which limit the usefulness of ART.
To minimize side effects associated with dosage during chemotherapy, a promising 
approach is to combine a conventional chemotherapy with new strategies to maximize 
efficacy of tumor treatment through inducing cell apoptosis. Recent studies demon-
strate that nanotechnologies and nanoparticles, which have unique peculiarities such 
as stable biomolecular absorption, high surface energy, and small sizes comparable to 
those of biomolecules, are becoming a focus for human medical application, including 
the delivery of antineoplastic agents to cells and tissues.10,11 We have recently reported International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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that MNPs-Fe3O4, as an anticancer drug deliverer, could 
enhance the sensitivity of anticancer drugs and reverse the 
drug resistance of tumor cells.12,13
Apoptosis is the main mechanism of cell death, and 
is mediated by a cell-intrinsic suicide program, with the 
relative balance of pro- and anti-apoptotic signaling path-
ways determining the fate of the cell. There are two main 
pathways in mammals. One is the death receptor signaling 
pathway,14 which is regulated by the IAP family includ-
ing mainly X-IAP, c-IAP1, c-IAP2, KIAP, and survivin. 
Another pathway is the mitochondrial signaling pathway, 
in which bcl-2 plays an important role and bcl-2/bax is the   
key point of cell apoptosis.15 Recently, bcl-rambo, a novel 
member of bcl-2 family, has been shown to induce apoptosis 
independent of both bcl-2/bax ratio and the death receptor 
pathway, but this effect can be specifically blocked by the 
IAP family.16 The final executor of apoptosis is the caspase 
family, particularly caspase-3, which is the central proteases 
for apoptosis.17
Accordingly, the copolymer of ART with MNPs-Fe3O4 
may provide a novel clinical candidate for the treatment 
of leukemia. Here, the sensitivity of K562 cells to this 
copolymer and its possible underlying mechanisms were 
investigated.
Materials and methods
Main materials
The following materials were purchased: 3-(4, 5- 
dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide 
(MTT) (Ameresco, Solon, OH); Z-VAD-FMK (Beyotime 
Biotechnology); RPMI 1640 medium and fetal calf 
serum (GIBCO, USA); artesunate (Guilin Pharma-
ceutical Co., Ltd., China); Annexin V-FITC (Biosea 
Biotechnology Co., Ltd., Beijing, China); total protein 
extraction kit P1250 (Applygen Technologies Inc., 
Beijing, China); BCA protein assay kit (Biosynthesis   
Biotechnology Co., Ltd., Beijing, China); anti-bcl-2, anti-
bax, anti-survivin (Bioworld), anti-bcl-rambo (Biovision), 
anti-active caspase-3 (Cell Signaling), anti-GAPDH (Santa 
Cruz, CA),  and goat-antirabbit HRP-IgG (Santa Cruz, CA); 
Western chemiluminescent HRP substrate (Millipore Cor-
poration, Billerica, MA). MNPs-Fe3O4 was kindly supplied 
by the state Key Laboratory of Bioelectronics, Southeast 
University, Nanjing, China, and was well distributed in 0.01 
M phosphate-buffered saline (PBS) by ultrasound to obtain 
MNPs-Fe3O4 colloidal suspension. ART at different concen-
trations (12.5, 25, 50, 75, and 100 µM) was conjugated with 
MNPs-Fe3O4, at the molar ratios of 25:1, 50:1, and 100:1 by   
mechanical absorption polymerization at 4°C for 12 hours, 
as previously reported.18,19
cell line and cell culture
K562 cells, derived from a patient with chronic myeloid 
leukemia in blast crisis, had been constantly preserved 
in our laboratory, and were cultured in a flask in RPMI 
1640 medium supplemented with 10% fetal calf serum, 
100 U/mL penicillin, and 100 µg/mL streptomycin at 37°C 
in a humidified 5% CO2 incubator.
cytotoxicity assays
K562 cells (2 × 104 cells per well) in logarithmic growth 
phase were cultured in 96-well flat-bottomed plates in a 
triplicate pattern and treated with different concentrations of 
ART, MNPs-Fe3O4, or the copolymer of ART with MNPs-
Fe3O4 in the presence or absence of 40 µM Z-VAD-FMK for 
48 hours. MTT (20 µL, 5 mg/mL) was added to each well 
and incubated for 4 hours. Then, 200 µL of dimethylsulfox-
ide was added to each well and the plate was vortexed for   
10 minutes at 37°C. Finally, the optical density value (A) of 
each well was measured at a measurement wavelength of 
540 nm using a plate reader (Model 550, BIO-RAD, Japan). 
Cell growth inhibition ratio was calculated as (1 − A540 of 
experimental well/A540 of blank control well) × 100%. Each 
assay was repeated at least 3 times.
Apoptosis assay by flow cytometry
Based on the results of cytotoxicity assay, the best combina-
tion condition of ART with MNPs-Fe3O4 (100:1 M/M) was 
used to measure the apoptosis rate. Briefly, after being treated 
with ART, MNPs-Fe3O4 or the copolymer of MNPs-Fe3O4 and 
ART for 48 hours, K562 cells were collected, washed twice 
with ice-cold PBS, and then cells was suspended in 200 µL of 
binding buffer and 10 µL of Annexin V-FITC for 15 minutes 
in the dark. Thereafter, 300 µL of binding buffer and 5 µL 
of propidium iodide were added to each sample. Finally, the 
cells were analyzed using BD FACSDiva flow cytometry (BD 
FACS CantoTM II) with Cell Quest software.
Western blot analysis
After K562 cells were treated as mentioned above, total 
protein was extracted and quantified according to the manu-
facturer’s protocol. Each equal amount of protein was loaded 
on sodium dodecyl sulfate polyacrylamide gel, run at 100 
volts for 2 hours, and then the protein was transferred to a 
polyvinylidene fluoride membrane. The membranes were 
blocked in 5% fat-free milk at room temperature for 2 hours, International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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and the blots were stained with specific primary antibodies, 
including anti-bcl-2, anti-bax, anti-survivin, anti-bcl-rambo, 
anti-active caspase-3, and anti-GAPDH antibodies overnight 
at 4°C. Then, the membranes were washed and incubated 
with goat-antirabbit HRP-IgG for 1 hour at room temperature, 
and imaged with a chemiluminescent substrate. Thereafter, 
the bound immunoglobulins were removed from the mem-
branes by washing twice with restore western blot stripping 
buffer, and the signal was detected using the ChemiDoc 
XRs+ (BIO-RAD) with the enhanced chemiluminescence 
and analyzed by the Image Lab (ECL). GAPDH was used 
as the internal control.
statistical analysis
All experiments were repeated 3 times. Data are presented 
as mean ± standard deviation and analyzed using the SPSS 
(Release13.0; SPSS Inc, Chicago, IL). One-way analysis of 
variance (ANOVA), 2-sample t-test, or rank test was per-
formed to illustrate the significant difference between the 
treated groups and the control. The difference was considered 
statistically significant at P , 0.05.
Results
Inhibition of cell growth
When K562 cells were treated with the copolymer of ART 
and MNPs-Fe3O4 at the molar ratio of 100:1, the cell viability 
was decreased significantly compared with that of K562 cells 
treated with ART alone (0.47 ±  0.11 vs 1.10 ±  0.02) 
(P , 0.05). Although the cell viability of K562 cells was 
reduced to 0.66 ± 0.03 at a molar ratio of 25:1 and 0.73 ± 0.04 
at a molar ratio of 50:1, there were no significant differences 
between the copolymer and ART alone group (P . 0.05), 
suggesting that the molar ratio of 100:1 was the best condition 
for copolymerization.
Moreover, when ART at the concentrations of 75,   
or 100 µM was combined with MNPs-Fe3O4 (M/M = 100:1) 
cell proliferation was remarkably inhibited, especially at 
the concentration of 100 µM, compared with ART alone 
(P , 0.05) (Figure 1); however there was no significant 
difference at the concentrations of 12.5, 25, and 50 µM 
(P . 0.05). The cell growth inhibition in the MNPs-Fe3O4 
group was less than that in the ART group with or without 
MNPs-Fe3O4. In addition, it was noted that MNPs-Fe3O4 alone 
could slightly inhibit cell proliferation when its concentration 
was from 0.125 µM to 4 µM, but there was no significant 
difference (P . 0.05).
To further verify that caspase activation is necessary 
for the copolymer-induced apoptosis, K562 cells were 
treated with the copolymer of ART and MNPs-Fe3O4 
in the   presence or absence of general caspase inhibitor 
Z-VAD-FMK. Cell survival rate was measured to see 
whether the antiproliferative effect of the copolymer was 
preventable. As shown in Figure 2, the copolymer-induced 
cell death was attenuated by Z-VAD-FMK, since cell sur-
vival rate in the presence of Z-VAD-FMK was increased 
more than its absence (58.73 ± 0.37% vs 23.67 ± 1.45%) 
(P , 0.05), suggesting that in combination with MNPs-
Fe3O4, ART-induced apoptosis proceeded via the caspase-
dependent pathway.
enhancement of apoptosis by the 
copolymer of ArT with MNPs-Fe3O4
After being incubated with ART, MNPs-Fe3O4, or the 
copolymer of ART with MNPs-Fe3O4 (M/M = 100:1) for 
48 hours, the proportion of apoptotic cells in the copolymer 
treated group was increased significantly compared with 
that in 100 µM ART-treated group (78.02 ± 10.83% vs 
48.90 ± 14.08%) (P , 0.05) (Figure 3).
However, there were no significant differences in the 
apoptosis rate of K562 cells between the copolymer of 
12.5 µM ART with 0.125 µM MNPs-Fe3O4-treated group 
and the 12.5 µM ART-treated group (28.10 ± 11.66% vs 
17.64 ± 4.49%); between the copolymer of 25 µM ART 
with 0.25 µM MNPs-Fe3O4-treated group and the 25 µM 
ART-treated group (40.54 ± 13.45% vs 25.76 ± 8.80%); 
between the copolymer of 50 µM ART with 0.5 µM MNPs-
Fe3O4-treated group and the 50 µM ART alone group 
(44.95 ± 13.66% vs 38.98 ± 14.57%); and between the 
copolymer of 75 µM ART with 0.75 µM MNPs-Fe3O4-treated 
group and the 75 µM ART alone group (43.9 ± 5.53% vs 
38.53 ± 2.10%) (P . 0.05) (Figures 3 and 4). However, 
the apoptosis rate in all groups was higher than that in both 
MNPs-Fe3O4 and control groups (P , 0.05). These results 
to some extent indicate that MNPs-Fe3O4 may enhance ART-
induced cell apoptosis.
expression of bcl-2, bax, bcl-rambo, 
caspase-3, and survivin
Western blot assay was performed to trace the changes of 
apoptosis-related genes on treatment with MNPs-Fe3O4, 
ART, or the copolymer of ART with MNPs-Fe3O4 for 
48 hours. It was observed that the expression of survivin 
was downregulated in the ART group, and this downregula-
tion was even more apparent in the group of copolymer of 
ART with MNPs-Fe3O4. The levels of bax and bcl-2 were 
increased in both ART group and the copolymer of ART International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Figure 1 The inhibition ratio of K562 treated with ArT or the copolymer of ArT with MNPs-Fe3O4 (100:1) for 48 hours.
Note: *P , 0.05, compared with the ArT alone.
Abbreviations: MNPs-Fe3O4, magnetic nanoparticles of Fe3O4; ArT, artesunate.
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Figure 2 effect of 1.0 µM MNPs-Fe3O4, 100 µM ArT, and the copolymer of ArT with MNPs-Fe3O4 (100:1) on the cell viability in the presence or absence of 40 µM Z-VAD-
FMK for 48 hours.
Note: *P , 0.05, compared with the absence of Z-VAD-FMK.
Abbreviations: MNPs-Fe3O4, magnetic nanoparticles of Fe3O4; ArT, artesunate.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1189
Interaction of Fe3O4 magnetic nanoparticles and artesunate
0.1%
Q1 Q2
Q3 Q4
2.0%
94.2% 3.7%
102 101 100 103
Annexin-V FITC
A
P
I
104 105 102 101 100 103 104 105
102 101 100 103 104 105 102 101 100 103 104 105
0.1%
Q1 Q2
Q3 Q4
0.2%
95.8% 3.9%
Annexin-V FITC
B
1.4%
Q1 Q2
Q3 Q4
22.6%
46.7% 29.3%
Annexin-V FITC
C
P
I
P
I
P
I
1
0
2
1
0
1
1
0
0
1
0
3
1
0
4
1
0
5
D
1
0
3
1
0
2
1
0
1
1
0
0
1
0
4
1
0
5 1.3%
Q1 Q2
Q3 Q4
36.2%
5.2% 57.3%
Annexin-V FITC
1
0
2
1
0
1
1
0
0
1
0
3
1
0
4
1
0
5
1
0
2
1
0
1
1
0
0
1
0
3
1
0
4
1
0
5
Figure 3 Apoptosis of K562 cells treated with ArT or the copolymer of ArT with MNPs-Fe3O4 for 48 hours. A) control; B) 1 µM MNPs-Fe3O4; C) 100 µM ArT; D) the 
copolymer of 100 µM ArT with 1 µM MNP-Fe3O4.
Abbreviations: MNPs-Fe3O4, magnetic nanoparticles of Fe3O4; ArT, artesunate.
with   MNPs-Fe3O4 group compared with control group and 
MNPs-Fe3O4 group (see Figure 5, P , 0.05), but there was 
no obvious difference in the bcl-2/bax ratio. The levels of 
bcl-rambo and caspase-3 were upregulated when the ART 
was combined with the MNPs-Fe3O4 (P , 0.05). These 
results suggest that the copolymer of ART with MNPs-Fe3O4 
triggers changes in the expression levels of apoptosis-related 
genes in K562 cells, among which upregulation of bcl-
rambo and downregulation of survivin are the two major   
alterations.
Discussion
ART could inhibit the proliferation of tumor cells in vitro and 
in vivo by downregulating the Wnt/β-catenin pathway.4,20 How-
ever, toxicity of ART to blood vessels and bone is an obstacle 
for clinical application of ART, which has limited its wide-
spread application. Nowadays, MNP-Fe3O4 as a targeted drug 
carrier with target orientation and   sustained-release properties 
has been widely studied in medical research. It has been previ-
ously reported that MNP-Fe3O4 with anticancer drugs could 
effectively improve efficiency of chemotherapeutic agents 
which has a synergistic effect in multidrug resistance.12,13
Our present study demonstrated that the unique MNPs-
Fe3O4 could increase the biological effects and decrease the 
side effects of ART. MTT results revealed that after being 
combined with MNPs-Fe3O4 (100:1, M/M), ART showed 
an enhanced cytotoxic effect on K562 cells; the copolymer 
of 100 µM ART with 1 µM MNPs-Fe3O4 had the most 
enhanced cytotoxicity among the five groups. Interestingly, 
the copolymer of ART and MNPs-Fe3O4-induced cell death 
was attenuated since cell survival rate was increased by 
Z-VAD-FMK, suggesting that the copolymer of ART and 
MNPs-Fe3O4-induced apoptosis proceeded via the caspase-
dependent pathway.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Figure 4 Apoptosis ratio of K562 cells treated with different concentrations of ArT or the copolymer of different concentrations of ArT with different concentrations of 
MNPs-Fe3O4.
Notes: *P , 0.05, compared with ArT alone.
Abbreviations: MNPs-Fe3O4, magnetic nanoparticles of Fe3O4; ArT, artesunate.
Apoptosis, as a process of programmed cell death, is 
normal for the development and health of multicellular 
organisms.14 Apoptotic obstruction is an important event 
in a tumor genesis, and apoptosis-oriented treatment is 
common in cancer treatment. Our present studies show the 
copolymer of 100 µM ART with 1 µM MNPs-Fe3O4 could 
significantly induce K562 cell apoptosis (P , 0.05), and the 
apoptosis induced by ART was dose-dependent, as has been 
reported in other tumor cells.1–3 These results to some extent 
indicate that MNPs-Fe3O4 can enhance the ART-induced   
apoptosis.
Apoptosis is the consequence of a series of precisely 
regulated events that are frequently altered in tumor cells. 
ART-induced cell apoptosis is apparently involved in the 
death receptor pathway and the mitochondria.21–23 The   
relative ratios of the various bcl-2 family members such as 
bcl-2/bax could determine how much cellular stress was 
needed to induce apoptosis.24,25 A recent report showed that 
bcl-rambo, located in mitochondria, contained conserved 
bcl-2 homology (BH) motifs 1, 2, 3, 4. But no interaction 
was found between bcl-rambo with either anti-apoptotic 
(bcl-2, bcl-Xl, bcl-w, A1, MCL-1, E1B-19K, and BHRF1) 
or pro-apoptotic (bax, bak, bik, bid, bim, and bad ). Its over-
expression induces apoptosis by the C-terminal membrane 
anchor region which was preceded by a unique 250 amino 
acid insertion containing two tandem repeats. This function 
was inhibited only by the IAP family.15,16 Our results showed 
that treatment with the copolymer of ART with MNPs-Fe3O4 
upregulated the expression of bcl-2, bax, bcl-rambo and 
active caspase-3 protein. It is worth noting that expression 
of bcl-2 in the copolymer-treated group shows an increasing 
trend (P , 0.05). Although the expression of bax was also 
increased, the computer-assisted image analysis shows that 
in combination with MNPs-Fe3O4, the ratio of bcl-2/bax in 
K562 cells was in a slightly ascendant trend compared with 
ART alone (P . 0.05), suggesting that MNPs-Fe3O4 enhanced 
ART-apoptosis through bcl-2/bax-independent mechanism, 
which differs from the results previously published.24,25
On the other hand, studies showed that Wnt/β-catenin, 
as an important self-renewal pathway,20 could regulate the 
transcription of survivin, p53, and c-myc. Overexpression 
of survivin has been detected in various hematological 
malignancies, including acute leukemias, myelodysplastic 
syndrome, chronic myeloid leukemia, and other types of International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
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lymphoid malignancies.26–28 Survivin can bind to and potently 
inhibit caspases, including caspase-3.29
Caspases are synthesized as proenzymes and can be acti-
vated by proteolysis at several sites. The active caspase-3 is a 
heterotetramer of two large and two small subunits.30 In our 
present study, the downregulation of survivin expression and a 
significant increase in the expression of active caspase-3 pro-
tein were observed at the same time in the K562 cells treated 
with the copolymer of MNPs-Fe3O4 and ART, suggesting that 
the potent inhibition of survivin expression could augment the 
activity of caspase-3, thus substantially enhancing apoptosis 
of K562 cells induced by the combination of MNPs-Fe3O4   
with ART.
Conclusion
In summary, these results showed that MNPs-Fe3O4 could 
enhance ART-induced apoptosis in K562 cells, which may be 
related to the upregulation of bcl-rambo and downregulation 
of survivin. It would be worthwhile evaluating the effects 
of the copolymer on normal cells in vitro for clinical 
application.
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